Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Magnesium chloride + dextrose monohydrate + calcium chloride + sodium lactate + sodium chloride** is a multi-electrolyte, dextrose-based peritoneal dialysis solution. Dextrose establishes an osmotic gradient across the peritoneal membrane to promote ultrafiltration and removal of excess water and solutes, while sodium, lactate, calcium, and magnesium provide electrolyte and buffer support during dialysis. It is administered intraperitoneally for peritoneal dialysis in renal failure. Products containing this exact active-ingredient set include DELFLEX and DIANEAL formulations, which are supplied in multiple dextrose strengths and calcium/magnesium concentrations. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a98facd6-9daa-4d37-8209-63a0599dbfaa))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on magnesium chloride + dextrose monohydrate + calcium chloride + sodium lactate + sodium chloride.